Moderna
MRNA
#1416
Rank
C$17.77 B
Marketcap
$45.98
Share price
2.03%
Change (1 day)
-68.48%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -C$4.97 Billion

According to Moderna 's latest financial reports the company's current earnings are C$3.19 Billion. , an increase over its 2023 earnings that were of -C$5.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -C$5.13 Billion-8.22%
2023 -C$5.59 Billion-140.65%
2022 C$13.74 B-27.81%
2021 C$19.04 B-1911.15%
2020 -C$1.06 Billion44.7%
2019 -C$0.73 Billion28.63%
2018 -C$0.57 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$59.22 Million-98.85%๐Ÿ‡บ๐Ÿ‡ธ USA
C$30.35 B-691.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$59.79 Million-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.34 Billion-93.43%๐Ÿ‡บ๐Ÿ‡ธ USA
C$19.52 B-480.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-C$0.86 Billion-83.25%๐Ÿ‡บ๐Ÿ‡ธ USA
C$24.96 B-586.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.17 Billion-96.72%๐Ÿ‡บ๐Ÿ‡ธ USA